SOPH logo

SOPHIA GENETICS SA

SOPHNASDAQ
🏆 #2741 by market capUS Equity
$69.63▲ $0.05 (+0.07%)
Simulated price
🔔
Track SOPH
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 0.1%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$700M
Small Cap
📈Revenue Growth (YoY)
+18.6%
Healthy
📊Gross Margin
66.6%
High
💵FCF Margin
-53.0%
Thin
⚖️P/S Ratio
8.1x
Elevated
Otter Score
60
Fair
No chart data available for SOPH.

Trading Snapshot

Day Range
$69.15 – $70.94
52-Week Range
$3.75 – $8.98
Volume
$2.03B
Avg Volume
$1.66B
Shares Outstanding
83.9M
Next Earnings
Nov 30, 2026

Fundamentals Snapshot

Annual Revenue
$77M
Last Q Revenue
$23M
P/E Ratio
-7.3
P/S Ratio
8.1x
EPS (TTM)
$-1.10
Dividend Yield
0.00%
Dilution (1yr)
+3.5%

Why Investors Own SOPH

  • ✓High-growth profile — revenue up +25.2% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 61% gross margin and 13% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

SOPH logo

SOPHIA GENETICS SA

SOPH
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$77M▲ +18.6% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
61.9%▼ −8.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$71M▲ +6.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$39M▼ −24.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
68.2M▲ +3.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$7M▼ −$43M YoY
StockOtter · stockotter.space

About SOPHIA GENETICS SA

SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
60/100

Analyst Price Target

ⓘ
Average Target
$80.32
▲ +15.4% Upside
High Target$99.00
Low Target$73.40
Based on 11 analysts

Latest News & Updates

🚀
CNBC·2h ago

SOPHIA GENETICS SA tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
MarketWatch·5h ago

Analysts lift SOPH price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Reuters·1d ago

SOPHIA GENETICS SA announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.